{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:07:23Z","timestamp":1790719643723,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":3652,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1017\/s1041610214001756","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T13:38:31Z","timestamp":1409233111000},"page":"131-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia"],"prefix":"10.1016","volume":"27","author":[{"given":"Shani","family":"Pridan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnina","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Baruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Tadger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Plopski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610214001756_bb0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjopharm.2008.10.003","article-title":"Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients","volume":"6","author":"Aparasu","year":"2008","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"key":"10.1017\/S1041610214001756_bb0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0010-440X(99)90134-7","article-title":"Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy","volume":"40","author":"Barak","year":"1999","journal-title":"Comprehensive Psychiatry"},{"key":"10.1017\/S1041610214001756_bb0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/10673221003747690","article-title":"The elderly safety imperative and antipsychotic usage","volume":"18","author":"Chahine","year":"2010","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1017\/S1041610214001756_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004714-199508000-00002","article-title":"Effect of risperidone on hostility in schizophrenia","volume":"15","author":"Czobor","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1017\/S1041610214001756_bb0030","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/1099-1166(200006)15:6<506::AID-GPS146>3.0.CO;2-V","article-title":"A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group","volume":"15","author":"Davidson","year":"2000","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610214001756_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.schres.2009.12.029","article-title":"Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study","volume":"117","author":"De Hert","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1017\/S1041610214001756_bb0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/089198879400700209","article-title":"Clozapine in the elderly","volume":"7","author":"Frankenburg","year":"1994","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1017\/S1041610214001756_bb0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14740338.7.5.525","article-title":"The safety of clozapine in the elderly","volume":"7","author":"Gareri","year":"2008","journal-title":"Expert Opinion Drug Safety"},{"key":"10.1017\/S1041610214001756_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2013.05.001","article-title":"Risk of neutropenia in a clozapine-treated elderly population","volume":"148","author":"Guenette","year":"2013","journal-title":"Schizophrenia Research"},{"key":"10.1017\/S1041610214001756_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/00048679709073852","article-title":"Is clozapine safe in the elderly?","volume":"31","author":"Herst","year":"1997","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1017\/S1041610214001756_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v60n0109","article-title":"The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia","volume":"60","author":"Howanitz","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610214001756_bb0065","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","article-title":"A systematic review and meta-analysis of recovery in schizophrenia","volume":"39","author":"J\u00e4\u00e4skel\u00e4inen","year":"2013","journal-title":"Schizophrenia Bullettin"},{"key":"10.1017\/S1041610214001756_bb0070","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1017\/S1041610214001756_bb0075","first-page":"CD005580","article-title":"Antipsychotic medication for elderly people with schizophrenia","volume":"1","author":"Marriott","year":"2006","journal-title":"Cochrane Database Systemic Reviews"},{"key":"10.1017\/S1041610214001756_bb0080","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610214001756_bb0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: balancing safety with superior antipsychotic efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clinical Schizophrenia and Related Psychoses"},{"key":"10.1017\/S1041610214001756_bb0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1099-1166(199705)12:5<553::AID-GPS547>3.0.CO;2-U","article-title":"Outcome of clozapine therapy for elderly patients with refractory primary psychosis","volume":"12","author":"Sajatovic","year":"1997","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610214001756_bb0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1176\/appi.ps.201300180","article-title":"Geographic and clinical variation in clozapine use in the United States","volume":"65","author":"Stroup","year":"2014","journal-title":"Psychiatric Services"},{"key":"10.1017\/S1041610214001756_bb0100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1017\/S1041610214001756_bb0105","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/cn400121z","article-title":"Classics in chemical neuroscience: clozapine","volume":"4","author":"Wenthur","year":"2013","journal-title":"ACS Chemical Neuroscience"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224004587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224004587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610214001756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T13:17:05Z","timestamp":1736428625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224004587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1041610224004587"],"URL":"https:\/\/doi.org\/10.1017\/s1041610214001756","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610214001756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}